SSKN News and Press, Strata Skin Sciences Inc. From 11/09/22

Strong revenue in the third quarter 2022 of $9.4 million, a 22% increase over the third quarter of 2021 Strong international sales of $3.3 million, an 82% increase over the third quarter of 2021 Announced U.S. commercial launch of TheraClear ® X acne the...

HORSHAM, Pa., Oct. 26, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its third...

HORSHAM, Pa., Oct. 06, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the company will present at the Mi...

BRANFORD, Conn., Aug. 23, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO) (“IsoPlexis”), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced the appointment of Nachum “Homi” Shamir to its ...

STRATA Skin Sciences, Inc. (SSKN) Q2 2022 Earnings Conference Call August 10, 2022, 04:30 PM ET Company Participants Leigh Salvo - Investor Relations Robert Moccia - Chief Executive Officer Christopher Lesovitz - Chief Financial Officer Conference Call Part...

STRATA Skin Sciences press release ( NASDAQ: SSKN ): Q2 GAAP EPS of -$0.05 in-line. Revenue of $9.1M (+23.0% Y/Y) beats by $0.96M . STRATA continues to expect full year 2022 revenue to range from $33.0 million to $35.0 million, representing 10% to 17% year over yea...

HORSHAM, Pa., Aug. 10, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the second q...

HORSHAM, Pa., Aug. 02, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that the Company’s XTRAC Ex...

HORSHAM, Pa., July 27, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its secon...

Strata Skin Sciences ( NASDAQ: SSKN ) on Monday announced the U.S. commercial launch of its acne treatment TheraClear X. Shares of the company soared ~18% after hours to $1.39. The company said the TheraClearX Acne Therapy System is engineered and indicated spe...